{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T08:28:24Z","timestamp":1789720104836,"version":"4.0.1"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004586","name":"Funda\u00e7\u00e3o Carlos Chagas Filho de Amparo \u00e0 Pesquisa do Estado do Rio de Janeiro","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004586","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006507","name":"Funda\u00e7\u00e3o Oswaldo Cruz","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100006507","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Retrovirology"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12977-018-0458-6","type":"journal-article","created":{"date-parts":[[2018,12,12]],"date-time":"2018-12-12T14:26:29Z","timestamp":1544624789000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Reduction of inflammation and T cell activation after 6\u00a0months of cART initiation during acute, but not in early chronic HIV-1 infection"],"prefix":"10.1186","volume":"15","author":[{"given":"Hury Hellen Souza","family":"de Paula","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Cristina Garcia","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diogo Gama","family":"Caetano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edson","family":"Delatorre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvia Lopes Maia","family":"Teixeira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lara Esteves","family":"Coelho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduarda Grinsztejn","family":"Jo\u00e3o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle Morata","family":"de Andrade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra Wagner","family":"Cardoso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz","family":"Grinsztejn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valdilea Gon\u00e7alves","family":"Veloso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariza Gon\u00e7alves","family":"Morgado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monick Lindenmeyer","family":"Guimar\u00e3es","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernanda Heloise","family":"C\u00f4rtes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,12,12]]},"reference":[{"issue":"9903","key":"458_CR1","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1016\/S0140-6736(13)61809-7","volume":"382","author":"SG Deeks","year":"2013","unstructured":"Deeks SG, Lewin SR, Havlir DV. The end of AIDS: HIV infection as a chronic disease. Lancet. 2013;382(9903):1525\u201333.","journal-title":"Lancet"},{"issue":"12","key":"458_CR2","doi-asserted-by":"publisher","first-page":"e1004543","DOI":"10.1371\/journal.ppat.1004543","volume":"10","author":"A Schuetz","year":"2014","unstructured":"Schuetz A, Deleage C, Sereti I, Rerknimitr R, Phanuphak N, Phuang-Ngern Y, Estes JD, Sandler NG, Sukhumvittaya S, Marovich M, et al. Initiation of ART during early acute HIV infection preserves mucosal Th17 function and reverses HIV-related immune activation. PLoS Pathog. 2014;10(12):e1004543.","journal-title":"PLoS Pathog"},{"issue":"1","key":"458_CR3","doi-asserted-by":"publisher","first-page":"21163","DOI":"10.7448\/IAS.19.1.21163","volume":"19","author":"TA Crowell","year":"2016","unstructured":"Crowell TA, Fletcher JL, Sereti I, Pinyakorn S, Dewar R, Krebs SJ, Chomchey N, Rerknimitr R, Schuetz A, Michael NL, et al. Initiation of antiretroviral therapy before detection of colonic infiltration by HIV reduces viral reservoirs, inflammation and immune activation. J Int AIDS Soc. 2016;19(1):21163.","journal-title":"J Int AIDS Soc"},{"key":"458_CR4","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S2055-6640(20)30688-9","volume":"2","author":"J Ananworanich","year":"2016","unstructured":"Ananworanich J, Sacdalan CP, Pinyakorn S, Chomont N, de Souza M, Luekasemsuk T, Schuetz A, Krebs SJ, Dewar R, Jagodzinski L, et al. Virological and immunological characteristics of HIV-infected individuals at the earliest stage of infection. J Virus Erad. 2016;2:43\u20138.","journal-title":"J Virus Erad"},{"issue":"2","key":"458_CR5","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1093\/cid\/ciw683","volume":"64","author":"I Sereti","year":"2017","unstructured":"Sereti I, Krebs SJ, Phanuphak N, Fletcher JL, Slike B, Pinyakorn S, O\u2019Connell RJ, Rupert A, Chomont N, Valcour V, et al. Persistent, Albeit reduced, chronic inflammation in persons starting antiretroviral therapy in acute HIV infection. Clin Infect Dis. 2017;64(2):124\u201331.","journal-title":"Clin Infect Dis"},{"issue":"3","key":"458_CR6","doi-asserted-by":"publisher","first-page":"e33948","DOI":"10.1371\/journal.pone.0033948","volume":"7","author":"J Ananworanich","year":"2012","unstructured":"Ananworanich J, Schuetz A, Vandergeeten C, Sereti I, de Souza M, Rerknimitr R, Dewar R, Marovich M, van Griensven F, Sekaly R, et al. Impact of multi-targeted antiretroviral treatment on gut T cell depletion and HIV reservoir seeding during acute HIV infection. PLoS One. 2012;7(3):e33948.","journal-title":"PLoS One"},{"issue":"8","key":"458_CR7","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1093\/infdis\/jit311","volume":"208","author":"V Jain","year":"2013","unstructured":"Jain V, Hartogensis W, Bacchetti P, Hunt PW, Hatano H, Sinclair E, Epling L, Lee TH, Busch MP, McCune JM, et al. Antiretroviral therapy initiated within 6\u00a0months of HIV infection is associated with lower T-cell activation and smaller HIV reservoir size. J Infect Dis. 2013;208(8):1202\u201311.","journal-title":"J Infect Dis"},{"key":"458_CR8","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1146\/annurev.micro.50.1.825","volume":"50","author":"G Pantaleo","year":"1996","unstructured":"Pantaleo G, Fauci A. Immunopathogenesis of HIV infection. Annu Rev Microbiol. 1996;50:825\u201354.","journal-title":"Annu Rev Microbiol"},{"key":"458_CR9","first-page":"8","volume":"2017","author":"L Pastor","year":"1925","unstructured":"Pastor L, Urrea V, Carrillo J, Parker E, Fuente-Soro L, Jairoce C, Mandomando I, Naniche D, Blanco J. Dynamics of CD4 and CD8 T-cell subsets and inflammatory biomarkers during early and chronic HIV infection in mozambican adults. Front Immunol. 1925;2017:8.","journal-title":"Front Immunol"},{"issue":"8","key":"458_CR10","doi-asserted-by":"publisher","first-page":"3719","DOI":"10.1128\/JVI.01844-08","volume":"83","author":"AR Stacey","year":"2009","unstructured":"Stacey AR, Norris PJ, Qin L, Haygreen EA, Taylor E, Heitman J, Lebedeva M, DeCamp A, Li D, Grove D, et al. Induction of a striking systemic cytokine cascade prior to peak viremia in acute human immunodeficiency virus type 1 infection, in contrast to more modest and delayed responses in acute hepatitis B and C virus infections. J Virol. 2009;83(8):3719\u201333.","journal-title":"J Virol"},{"issue":"12","key":"458_CR11","first-page":"3544","volume":"119","author":"B Jacquelin","year":"2009","unstructured":"Jacquelin B, Mayau V, Targat B, Liovat AS, Kunkel D, Petitjean G, Dillies MA, Roques P, Butor C, Silvestri G, et al. Nonpathogenic SIV infection of African green monkeys induces a strong but rapidly controlled type I IFN response. J Clin Invest. 2009;119(12):3544\u201355.","journal-title":"J Clin Invest"},{"issue":"1","key":"458_CR12","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1001\/jama.300.1.51","volume":"300","author":"K Bhaskaran","year":"2008","unstructured":"Bhaskaran K, Hamouda O, Sannes M, Boufassa F, Johnson AM, Lambert PC, Porter K. Changes in the risk of death after HIV seroconversion compared with mortality in the general population. JAMA. 2008;300(1):51\u20139.","journal-title":"JAMA"},{"issue":"9142","key":"458_CR13","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1016\/S0140-6736(98)03201-2","volume":"352","author":"A Mocroft","year":"1998","unstructured":"Mocroft A, Vella S, Benfield TL, Chiesi A, Miller V, Gargalianos P, d\u2019Arminio Monforte A, Yust I, Bruun JN, Phillips AN, et al. Changing patterns of mortality across Europe in patients infected with HIV-1. EuroSIDA Study Group. Lancet. 1998;352(9142):1725\u201330.","journal-title":"Lancet"},{"issue":"13","key":"458_CR14","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1056\/NEJM199803263381301","volume":"338","author":"FJ Palella Jr","year":"1998","unstructured":"Palella FJ Jr, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, Aschman DJ, Holmberg SD. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med. 1998;338(13):853\u201360.","journal-title":"N Engl J Med"},{"issue":"2","key":"458_CR15","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1097\/01.qai.0000179459.31562.16","volume":"41","author":"NF Crum","year":"2006","unstructured":"Crum NF, Riffenburgh RH, Wegner S, Agan BK, Tasker SA, Spooner KM, Armstrong AW, Fraser S, Wallace MR. Comparisons of causes of death and mortality rates among HIV-infected persons: analysis of the pre-, early, and late HAART (highly active antiretroviral therapy) eras. J Acquir Immune Defic Syndr. 2006;41(2):194\u2013200.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"2","key":"458_CR16","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1097\/01.qai.0000247229.68246.c5","volume":"44","author":"B Lau","year":"2007","unstructured":"Lau B, Gange SJ, Moore RD. Risk of non-AIDS-related mortality may exceed risk of AIDS-related mortality among individuals enrolling into care with CD4\u2009+\u2009counts greater than 200\u00a0cells\/mm3. J Acquir Immune Defic Syndr. 2007;44(2):179\u201387.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"10","key":"458_CR17","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1086\/652283","volume":"50","author":"ATC Collaboration","year":"2010","unstructured":"Collaboration ATC. Causes of death in HIV-1-infected patients treated with antiretroviral therapy, 1996-2006: collaborative analysis of 13 HIV cohort studies. Clin Infect Dis. 2010;50(10):1387\u201396.","journal-title":"Clin Infect Dis"},{"issue":"4","key":"458_CR18","doi-asserted-by":"publisher","first-page":"e59768","DOI":"10.1371\/journal.pone.0059768","volume":"8","author":"B Grinsztejn","year":"2013","unstructured":"Grinsztejn B, Luz PM, Pacheco AG, Santos DV, Velasque L, Moreira RI, Guimaraes MR, Nunes EP, Lemos AS, Ribeiro SR, et al. Changing mortality profile among HIV-infected patients in Rio de Janeiro, Brazil: shifting from AIDS to non-AIDS related conditions in the HAART era. PLoS One. 2013;8(4):e59768.","journal-title":"PLoS One"},{"issue":"12","key":"458_CR19","doi-asserted-by":"publisher","first-page":"e114661","DOI":"10.1371\/journal.pone.0114661","volume":"9","author":"CS Domingues","year":"2014","unstructured":"Domingues CS, Waldman EA. Causes of death among people living with AIDS in the pre- and post-HAART Eras in the city of Sao Paulo, Brazil. PLoS One. 2014;9(12):e114661.","journal-title":"PLoS One"},{"issue":"9939","key":"458_CR20","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/S0140-6736(14)60604-8","volume":"384","author":"CJ Smith","year":"2014","unstructured":"Smith CJ, Ryom L, Weber R, Morlat P, Pradier C, Reiss P, Kowalska JD, de Wit S, Law M, el Sadr W, et al. Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:A:D): a multicohort collaboration. Lancet. 2014;384(9939):241\u20138.","journal-title":"Lancet"},{"issue":"11","key":"458_CR21","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1093\/cid\/cir627","volume":"53","author":"G Guaraldi","year":"2011","unstructured":"Guaraldi G, Orlando G, Zona S, Menozzi M, Carli F, Garlassi E, Berti A, Rossi E, Roverato A, Palella F. Premature age-related comorbidities among HIV-infected persons compared with the general population. Clin Infect Dis. 2011;53(11):1120\u20136.","journal-title":"Clin Infect Dis"},{"issue":"10","key":"458_CR22","doi-asserted-by":"publisher","first-page":"e203","DOI":"10.1371\/journal.pmed.0050203","volume":"5","author":"LH Kuller","year":"2008","unstructured":"Kuller LH, Tracy R, Belloso W, De Wit S, Drummond F, Lane HC, Ledergerber B, Lundgren J, Neuhaus J, Nixon D, et al. Inflammatory and coagulation biomarkers and mortality in patients with HIV infection. PLoS Med. 2008;5(10):e203.","journal-title":"PLoS Med"},{"issue":"11","key":"458_CR23","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1093\/infdis\/jir134","volume":"203","author":"DR Boulware","year":"2011","unstructured":"Boulware DR, Hullsiek KH, Puronen CE, Rupert A, Baker JV, French MA, Bohjanen PR, Novak RM, Neaton JD, Sereti I. Higher levels of CRP, D-dimer, IL-6, and hyaluronic acid before initiation of antiretroviral therapy (ART) are associated with increased risk of AIDS or death. J Infect Dis. 2011;203(11):1637\u201346.","journal-title":"J Infect Dis"},{"issue":"3","key":"458_CR24","doi-asserted-by":"publisher","first-page":"e24243","DOI":"10.1371\/journal.pone.0024243","volume":"7","author":"L Ledwaba","year":"2012","unstructured":"Ledwaba L, Tavel JA, Khabo P, Maja P, Qin J, Sangweni P, Liu X, Follmann D, Metcalf JA, Orsega S, et al. Pre-ART levels of inflammation and coagulation markers are strong predictors of death in a South African cohort with advanced HIV disease. PLoS One. 2012;7(3):e24243.","journal-title":"PLoS One"},{"issue":"1","key":"458_CR25","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1111\/imr.12079","volume":"254","author":"M Paiardini","year":"2013","unstructured":"Paiardini M, Muller-Trutwin M. HIV-associated chronic immune activation. Immunol Rev. 2013;254(1):78\u2013101.","journal-title":"Immunol Rev"},{"issue":"6","key":"458_CR26","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1097\/QAD.0000000000000155","volume":"28","author":"E Hamlyn","year":"2014","unstructured":"Hamlyn E, Fidler S, Stohr W, Cooper DA, Tambussi G, Schechter M, Miro JM, McClure M, Weber J, Babiker A, et al. Interleukin-6 and D-dimer levels at seroconversion as predictors of HIV-1 disease progression. Aids. 2014;28(6):869\u201374.","journal-title":"Aids"},{"issue":"8","key":"458_CR27","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1093\/infdis\/jiw263","volume":"214","author":"TB Knudsen","year":"2016","unstructured":"Knudsen TB, Ertner G, Petersen J, Moller HJ, Moestrup SK, Eugen-Olsen J, Kronborg G, Benfield T. Plasma soluble CD163 level independently predicts all-cause mortality in HIV-1-infected individuals. J Infect Dis. 2016;214(8):1198\u2013204.","journal-title":"J Infect Dis"},{"issue":"6","key":"458_CR28","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1093\/infdis\/jiq118","volume":"203","author":"NG Sandler","year":"2011","unstructured":"Sandler NG, Wand H, Roque A, Law M, Nason MC, Nixon DE, Pedersen C, Ruxrungtham K, Lewin SR, Emery S, et al. Plasma levels of soluble CD14 independently predict mortality in HIV infection. J Infect Dis. 2011;203(6):780\u201390.","journal-title":"J Infect Dis"},{"issue":"8","key":"458_CR29","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1093\/infdis\/jiu238","volume":"210","author":"PW Hunt","year":"2014","unstructured":"Hunt PW, Sinclair E, Lecuroux C, Jacquelin B, Rodriguez B, Shive C, Clagett B, Funderburg N, Robinson J, Huang Y, Epling L, Martin JN, et al. Gut epithelial barrier dysfunction and innate immune activation predict mortality in treated HIV infection. J Infect Dis. 2014;210(8):1228\u201338.","journal-title":"J Infect Dis"},{"issue":"10","key":"458_CR30","doi-asserted-by":"publisher","first-page":"e46143","DOI":"10.1371\/journal.pone.0046143","volume":"7","author":"AS Liovat","year":"2012","unstructured":"Liovat AS, Rey-Cuille MA, Lecuroux C, Jacquelin B, Girault I, Petitjean G, Zitoun Y, Venet A, Barre-Sinoussi F, Lebon P, et al. Acute plasma biomarkers of T cell activation set-point levels and of disease progression in HIV-1 infection. PLoS One. 2012;7(10):e46143.","journal-title":"PLoS One"},{"issue":"8","key":"458_CR31","doi-asserted-by":"publisher","first-page":"e1005774","DOI":"10.1371\/journal.ppat.1005774","volume":"12","author":"MJ Ploquin","year":"2016","unstructured":"Ploquin MJ, Madec Y, Casrouge A, Huot N, Passaes C, L\u00e9curoux C, Essat A, Boufassa F, Jacquelin B, Jochems SP, et al. Elevated basal pre-infection CXCL10 in plasma and in the small intestine after infection are associated with more rapid HIV\/SIV disease onset. PLoS Pathog. 2016;12(8):e1005774.","journal-title":"PLoS Pathog"},{"issue":"3","key":"458_CR32","doi-asserted-by":"publisher","first-page":"ofw118","DOI":"10.1093\/ofid\/ofw118","volume":"3","author":"A Balagopal","year":"2016","unstructured":"Balagopal A, Gupte N, Shivakoti R, Cox AL, Yang WT, Berendes S, Mwelase N, Kanyama C, Pillay S, Samaneka W, et al. Continued elevation of interleukin-18 and interferon-gamma after initiation of antiretroviral therapy and clinical failure in a diverse multicountry human immunodeficiency virus cohort. Open Forum Infect Dis. 2016;3(3):ofw118.","journal-title":"Open Forum Infect Dis"},{"issue":"8","key":"458_CR33","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1086\/605890","volume":"200","author":"MA French","year":"2009","unstructured":"French MA, King MS, Tschampa JM, da Silva BA, Landay AL. Serum immune activation markers are persistently increased in patients with HIV infection after 6\u00a0years of antiretroviral therapy despite suppression of viral replication and reconstitution of CD4+ T cells. J Infect Dis. 2009;200(8):1212\u20135.","journal-title":"J Infect Dis"},{"issue":"5","key":"458_CR34","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1093\/jac\/dks533","volume":"68","author":"L Hocqueloux","year":"2013","unstructured":"Hocqueloux L, Avettand-Fenoel V, Jacquot S, Prazuck T, Legac E, Melard A, Niang M, Mille C, Le Moal G, Viard JP, et al. Long-term antiretroviral therapy initiated during primary HIV-1 infection is key to achieving both low HIV reservoirs and normal T cell counts. J Antimicrob Chemother. 2013;68(5):1169\u201378.","journal-title":"J Antimicrob Chemother"},{"issue":"5","key":"458_CR35","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1097\/QAI.0b013e318285cd33","volume":"62","author":"MJ Vinikoor","year":"2013","unstructured":"Vinikoor MJ, Cope A, Gay CL, Ferrari G, McGee KS, Kuruc JD, Lennox JL, Margolis DM, Hicks CB, Eron JJ. Antiretroviral therapy initiated during acute HIV infection fails to prevent persistent T-cell activation. J Acquir Immune Defic Syndr. 2013;62(5):505\u20138.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"458_CR36","doi-asserted-by":"crossref","unstructured":"Lundgren JD, Borges AH, Neaton JD: Serious Non-AIDS Conditions in HIV: Benefit of Early ART. Curr HIV\/AIDS Rep 2018.","DOI":"10.1007\/s11904-018-0387-y"},{"issue":"9","key":"458_CR37","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1056\/NEJMoa1506816","volume":"373","author":"JD Lundgren","year":"2015","unstructured":"Lundgren JD, Babiker AG, Gordin F, Emery S, Grund B, Sharma S, Avihingsanon A, Cooper DA, Fatkenheuer G, Llibre JM, et al. Initiation of antiretroviral therapy in early asymptomatic HIV infection. N Engl J Med. 2015;373(9):795\u2013807.","journal-title":"N Engl J Med"},{"issue":"3","key":"458_CR38","doi-asserted-by":"publisher","first-page":"e1003211","DOI":"10.1371\/journal.ppat.1003211","volume":"9","author":"A Saez-Cirion","year":"2013","unstructured":"Saez-Cirion A, Bacchus C, Hocqueloux L, Avettand-Fenoel V, Girault I, Lecuroux C, Potard V, Versmisse P, Melard A, Prazuck T, et al. Post-treatment HIV-1 controllers with a long-term virological remission after the interruption of early initiated antiretroviral therapy ANRS VISCONTI Study. PLoS Pathog. 2013;9(3):e1003211.","journal-title":"PLoS Pathog"},{"issue":"13","key":"458_CR39","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1097\/00002030-200309050-00005","volume":"17","author":"E Fiebig","year":"2003","unstructured":"Fiebig E, Wright D, Rawal B, Garrett P, Schumacher R, Peddada L, Heldebrant C, Smith R, Conrad A, Kleinman S, et al. Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection. AIDS. 2003;17(13):1871\u20139.","journal-title":"AIDS"},{"issue":"3","key":"458_CR40","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1093\/sysbio\/syq010","volume":"59","author":"S Guindon","year":"2010","unstructured":"Guindon S, Dufayard JF, Lefort V, Anisimova M, Hordijk W, Gascuel O. New algorithms and methods to estimate maximum-likelihood phylogenies: assessing the performance of PhyML 3.0. Syst Biol. 2010;59(3):307\u201321.","journal-title":"Syst Biol"},{"issue":"8","key":"458_CR41","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1038\/nmeth.2109","volume":"9","author":"D Darriba","year":"2012","unstructured":"Darriba D, Taboada GL, Doallo R, Posada D. jModelTest 2: more models, new heuristics and parallel computing. Nat Methods. 2012;9(8):772.","journal-title":"Nat Methods"},{"issue":"1","key":"458_CR42","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1128\/JVI.73.1.152-160.1999","volume":"73","author":"KS Lole","year":"1999","unstructured":"Lole KS, Bollinger RC, Paranjape RS, Gadkari D, Kulkarni SS, Novak NG, Ingersoll R, Sheppard HW, Ray SC. Full-length human immunodeficiency virus type 1 genomes from subtype C-infected seroconverters in India, with evidence of intersubtype recombination. J Virol. 1999;73(1):152\u201360.","journal-title":"J Virol"},{"issue":"8","key":"458_CR43","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1093\/infdis\/jir520","volume":"204","author":"TH Burdo","year":"2011","unstructured":"Burdo TH, Lo J, Abbara S, Wei J, DeLelys ME, Preffer F, Rosenberg ES, Williams KC, Grinspoon S. Soluble CD163, a novel marker of activated macrophages, is elevated and associated with noncalcified coronary plaque in HIV-infected patients. J Infect Dis. 2011;204(8):1227\u201336.","journal-title":"J Infect Dis"},{"issue":"11","key":"458_CR44","doi-asserted-by":"publisher","first-page":"e1006624","DOI":"10.1371\/journal.ppat.1006624","volume":"13","author":"JA McBride","year":"2017","unstructured":"McBride JA, Striker R. Imbalance in the game of T cells: What can the CD4\/CD8 T-cell ratio tell us about HIV and health? PLoS Pathog. 2017;13(11):e1006624.","journal-title":"PLoS Pathog"},{"key":"458_CR45","unstructured":"Protocolo Cl\u00ednico e diretrizes terap\u00eauticas para o manejo da infec\u00e7\u00e3o pelo HIV em adultos. http:\/\/www.aids.gov.br\/pcdt\/protocolo-clinico ."},{"issue":"5","key":"458_CR46","doi-asserted-by":"publisher","first-page":"e1004078","DOI":"10.1371\/journal.ppat.1004078","volume":"10","author":"S Serrano-Villar","year":"2014","unstructured":"Serrano-Villar S, Sainz T, Lee SA, Hunt PW, Sinclair E, Shacklett BL, Ferre AL, Hayes TL, Somsouk M, Hsue PY, et al. HIV-infected individuals with low CD4\/CD8 ratio despite effective antiretroviral therapy exhibit altered T cell subsets, heightened CD8+ T cell activation, and increased risk of non-AIDS morbidity and mortality. PLoS Pathog. 2014;10(5):e1004078.","journal-title":"PLoS Pathog"},{"issue":"9","key":"458_CR47","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1097\/QAD.0b013e32835faa72","volume":"27","author":"T Sainz","year":"2013","unstructured":"Sainz T, Serrano-Villar S, Diaz L, Gonzalez Tome MI, Gurbindo MD, de Jose MI, Mellado MJ, Ramos JT, Zamora J, Moreno S, et al. The CD4\/CD8 ratio as a marker T-cell activation, senescence and activation\/exhaustion in treated HIV-infected children and young adults. Aids. 2013;27(9):1513\u20136.","journal-title":"Aids"},{"issue":"2","key":"458_CR48","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1097\/QAI.0000000000000286","volume":"67","author":"L Zheng","year":"2014","unstructured":"Zheng L, Taiwo B, Gandhi RT, Hunt PW, Collier AC, Flexner C, Bosch RJ. Factors associated with CD8+ T-cell activation in HIV-1-infected patients on long-term antiretroviral therapy. J Acquir Immune Defic Syndr. 2014;67(2):153\u201360.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"5","key":"458_CR49","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1097\/01.qai.0000223028.55080.9d","volume":"42","author":"JB Margolick","year":"2006","unstructured":"Margolick JB, Gange SJ, Detels R, O\u2019Gorman MR, Rinaldo CR Jr, Lai S. Impact of inversion of the CD4\/CD8 ratio on the natural history of HIV-1 infection. J Acquir Immune Defic Syndr. 2006;42(5):620\u20136.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"10","key":"458_CR50","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1097\/QAD.0000000000001105","volume":"30","author":"V Mehraj","year":"2016","unstructured":"Mehraj V, Jenabian MA, Ponte R, Lebouche B, Costiniuk C, Thomas R, Baril JG, LeBlanc R, Cox J, Tremblay C, et al. The plasma levels of soluble ST2 as a marker of gut mucosal damage in early HIV infection. Aids. 2016;30(10):1617\u201327.","journal-title":"Aids"},{"key":"458_CR51","doi-asserted-by":"publisher","first-page":"404","DOI":"10.3389\/fimmu.2016.00404","volume":"7","author":"M Hoenigl","year":"2016","unstructured":"Hoenigl M, Perez-Santiago J, Nakazawa M, de Oliveira MF, Zhang Y, Finkelman MA, Letendre S, Smith D, Gianella S. (1\u2013\u2009>\u20093)-beta-d-glucan: a biomarker for microbial translocation in individuals with acute or early HIV infection? Front Immunol. 2016;7:404.","journal-title":"Front Immunol"},{"issue":"9","key":"458_CR52","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1093\/infdis\/jiu621","volume":"211","author":"EM Kahle","year":"2015","unstructured":"Kahle EM, Bolton M, Hughes JP, Donnell D, Celum C, Lingappa JR, Ronald A, Cohen CR, de Bruyn G, Fong Y, et al. Plasma cytokine levels and risk of HIV type 1 (HIV-1) transmission and acquisition: a nested case-control study among HIV-1\u2013serodiscordant couples. J Infect Dis. 2015;211(9):1451\u201360.","journal-title":"J Infect Dis"},{"issue":"8","key":"458_CR53","doi-asserted-by":"publisher","first-page":"4892","DOI":"10.4049\/jimmunol.174.8.4892","volume":"174","author":"JF Foley","year":"2005","unstructured":"Foley JF, Yu CR, Solow R, Yacobucci M, Peden KW, Farber JM. Roles for CXC chemokine ligands 10 and 11 in recruiting CD4+ T cells to HIV-1-infected monocyte-derived macrophages, dendritic cells, and lymph nodes. J Immunol. 2005;174(8):4892\u2013900.","journal-title":"J Immunol"},{"key":"458_CR54","first-page":"289","volume":"4","author":"CA Dinarello","year":"2013","unstructured":"Dinarello CA, Novick D, Kim S, Kaplanski G. Interleukin-18 and IL-18 binding protein. Front Immunol. 2013;4:289.","journal-title":"Front Immunol"},{"issue":"1","key":"458_CR55","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1159\/000353902","volume":"57","author":"JC Hernandez","year":"2014","unstructured":"Hernandez JC, Latz E, Urcuqui-Inchima S. HIV-1 induces the first signal to activate the NLRP3 inflammasome in monocyte-derived macrophages. Intervirology. 2014;57(1):36\u201342.","journal-title":"Intervirology"},{"issue":"13","key":"458_CR56","doi-asserted-by":"publisher","first-page":"3599","DOI":"10.1523\/JNEUROSCI.3045-16.2017","volume":"37","author":"ET Chivero","year":"2017","unstructured":"Chivero ET, Guo ML, Periyasamy P, Liao K, Callen SE, Buch S. HIV-1 tat primes and activates microglial NLRP3 inflammasome-mediated neuroinflammation. J Neurosci. 2017;37(13):3599\u2013609.","journal-title":"J Neurosci"},{"issue":"10","key":"458_CR57","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1093\/cid\/cix600","volume":"65","author":"L Pastor","year":"2017","unstructured":"Pastor L, Casellas A, Ruperez M, Carrillo J, Maculuve S, Jairoce C, Paredes R, Blanco J, Naniche D. Interferon-gamma-Inducible Protein 10 (IP-10) as a screening tool to optimize human immunodeficiency virus RNA monitoring in resource-limited settings. Clin Infect Dis. 2017;65(10):1670\u20135.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"458_CR58","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1089\/aid.2016.0126","volume":"33","author":"TC Leite","year":"2017","unstructured":"Leite TC, Campos DP, Coelho AB, Teixeira SL, Veloso V, Morgado MG, Guimaraes ML. Impact of HIV-1 subtypes on AIDS progression in a Brazilian cohort. AIDS Res Hum Retrovir. 2017;33(1):41\u20138.","journal-title":"AIDS Res Hum Retrovir"}],"container-title":["Retrovirology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12977-018-0458-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12977-018-0458-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12977-018-0458-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,17]],"date-time":"2020-11-17T11:51:57Z","timestamp":1605613917000},"score":1,"resource":{"primary":{"URL":"https:\/\/retrovirology.biomedcentral.com\/articles\/10.1186\/s12977-018-0458-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":58,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["458"],"URL":"https:\/\/doi.org\/10.1186\/s12977-018-0458-6","relation":{},"ISSN":["1742-4690"],"issn-type":[{"value":"1742-4690","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"1 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 December 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"76"}}